Tolerance and Efficacy of Rituximab in Sjogren's Disease.

Trial Profile

Tolerance and Efficacy of Rituximab in Sjogren's Disease.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 13 Mar 2015

At a glance

  • Drugs Rituximab (Primary)
  • Indications Sjogren's syndrome
  • Focus Therapeutic Use
  • Acronyms TEARS
  • Most Recent Events

    • 30 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
    • 30 Oct 2013 Post-hoc analysis for the impact of various endpoints on the sample size presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
    • 15 Jun 2013 Results presented at the 14th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top